Skip to content

What is the optimum way to approach external clinical vignette reviewers for the National Institute for Health Research's Health Technology Assessment (NIHR HTA) programme?: a factorial Randomised Controlled Trial

How do different approaches to obtaining information from clinical experts affect the quality of advice received in the NIHR HTA programme?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614000167662
Enrollment
460
Registered
2014-02-11
Start date
2014-01-16
Completion date
2014-10-09
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of this study it to determine the best way for the NIHR HTA programme to engage with clinical experts to ensure we prioritise the most important research questions for the NHS.

Interventions

Clinical experts who have agreed to provide advise to the NIHR HTA programme's vignette process (used to help prioritise questions for pragmatic clinical research) will be sent either a short (1 page- the intervention)) or long (up to 10 page - usual control) paper, and asked to provide advice on it using either a structured form (control) or free text (intervention) to reply. As a 2x2 factorial study the randomisations are short v long paper; and structured form v free text It is anticipated

Clinical experts who have agreed to provide advise to the NIHR HTA programme's vignette process (used to help prioritise questions for pragmatic clinical research) will be sent either a short (1 page- the intervention)) or long (up to 10 page - usual control) paper, and asked to provide advice on it using either a structured form (control) or free text (intervention) to reply. As a 2x2 factorial study the randomisations are short v long paper; and structured form v free text It is anticipated that the control group options (long paper and structured form) will take less than an hour to complete, with the intervention options (short paper and free text) shortening the required time for the participant.

Sponsors

Faculty of Medicine, University of Southampton
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Factorial
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used) (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
Yes

Inclusion criteria

Vignettes - all vignettes prepared during the Autumn 2013 and Spring 2014 prioritisation rounds of the NIHR HTA Programme Experts - all clinical experts included to comment on the prepared vignettes

Exclusion criteria

Vignettes - those which ask a methodological, rather than clinical question - vignettes where the responsible CA does not want external experts - Vignettes which have been through previous external review, other than as a panel topic Experts - Non-clinical experts, eg PPI advisors, methodologists. Clinical-Academics count as clinical experts. The final decision as to whether an advisor is 'clinical' rests with the Steering Group responsible for the vignette, who may take advice from the relevant CA - People who have provided advice on the panel topic from which the vignette was derived - Current and previous members of HTA prioritisation and TIDE panels

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 28, 2026